JAZZ

Jazz Pharmaceuticals Plc

A global biopharmaceutical company focused on rare diseases, Jazz Pharmaceuticals makes medicines for sleep disorders, epilepsy, and cancer. Its flagship products include Xywav for narcolepsy, Epidiolex for rare epilepsies, and the newer oncology drugs Ziihera and Modeyso. Founded in 2003 by Bruce Cozadd, the company took its name from the idea of jazz improvisation — innovating freely while staying grounded in a shared structure, much like musicians jamming together on stage.